ABSTRACT. DDD.Cg-A y female mice developed massive obesity as compared with B6.Cg-A y female mice. We previously identified quantitative trait loci (QTLs) for obesity on chromosomes 1, 6, 9 and 17 in F 2 female mice, including F 2 A y (F 2 mice with the A y allele) and F 2 non-A y mice (F 2 mice without the A y allele), produced by crossing C57BL/6J and DDD.Cg-A y strains. We here addressed the question whether the obesity QTLs share genetic bases with putative QTLs for plasma glucose, insulin and leptin concentrations. We performed QTL analyses for the first principal component (PC1) extracted from these metabolic measurements to identify the genes that contributed to the comprehensive evaluation of metabolic traits. By single QTL scans, we identified two significant QTLs for insulin concentration on chromosomes 6 and 12, three for leptin concentration on chromosomes 1, 6 and 17, and five for PC1 on chromosomes 1, 6, 12 (two loci) and 17. Although insulin and leptin concentrations and PC1 were not normally distributed in combined F 2 mice, results of single QTL scans by parametric and non-parametric methods were very similar. Therefore, QTL scan by the parametric method was performed with the agouti locus genotype as a covariate. A significant QTL × covariate interaction was found for PC1 on chromosome 9. All obesity QTLs had significant metabolic effects. Thus, obesity-and diabetes-related traits in DDD.Cg-A y mice were largely controlled by QTLs on chromosomes 1, 6, 9, 12 and 17.
Five single-gene obesity mutations, Cpe fat , Tub tub , Lep ob , Lepr db and A y , have been identified in mice [12] . Among these, only the A y allele is dominant and homozygous lethal; therefore, living A y mice are invariably heterozygotes. Obesity in A y mice is moderate and occurs late compared with the other four mutant mice.
In normal mice, the agouti gene is expressed only in the skin [5, 16] , and it regulates pigmentation by acting as an inverse agonist of the melanocortin 1 receptor [13, 19] . However, in A y mice, the A y allele is associated with a large deletion, causing agouti gene expression to be aberrantly controlled by an unrelated Raly gene promoter and leading to its ectopic overexpression [7, [14] [15] [16] . As a result, A y mice have a yellow coat color and develop maturity-onset obesity. Obesity in A y mice is believed to be due to the agouti protein, which acts as a constitutive antagonist of the melanocortin 3 receptor (MC3R) and melanocortin 4 receptor (MC4R) by mimicking the action of the agouti-related protein [6, 8, 18] .
DDD.Cg-A y female mice develop massive obesity compared with B6.Cg-A y female mice. We previously performed quantitative trait locus (QTL) analyses for obesity in two types of F 2 female mice [F 2 A y (F 2 mice carrying the A y allele at the agouti locus) and F 2 non-A y mice (F 2 mice without the A y allele)] produced by crossing C57BL/6J and DDD.Cg-A y inbred mouse strains [21] . We identified four significant obesity QTLs on chromosomes 1, 6, 9, and 17. The female strain DDD.Cg-A y is accordingly recognized as an animal model of multifactorial obesity.
In this study, to gain insight into the metabolic effect of these obesity QTLs, we investigated whether the obesity QTLs share genetic bases with putative QTLs for plasma glucose, insulin and leptin concentrations. In addition, QTL analyses of the first principal component (PC1) extracted from these metabolic measurements were performed to identify gene loci that contributed to the comprehensive evaluation of metabolic traits relevant to obesity and diabetes. QTLs for PCs are expected to be important, because they are likely to represent genetic factors accounting for metabolic syndrome. The obesity QTLs were characterized by performing these analyses.
MATERIALS AND METHODS

Mice:
The inbred mouse strain DDD/Sgn (hereafter designated as DDD; coat color genotype: AABBcc) and the congenic strain DDD.Cg-A y (hereafter designated as DDD-A y , A y ABBCC) are maintained at the National Institute of Agrobiological Sciences (NIAS). The inbred strain C57BL/6J (hereafter designated as B6, aaBBCC) was purchased from the Clea Japan Inc. (Tokyo, Japan). The congenic strain B6.Cg-A y (hereafter designated as B6-A y , A y aBBCC) was purchased from The Jackson Laboratory (Bar Harbor, ME, U.S.A.). The DDD-A y strain was established by introgressing the A y allele from the B6-A y strain into the DDD strain by backcrossing for 12 generations [20] .
DDD-A y males were crossed with B6 females to produce the F 1 generation, and F 1 A y (A y aBBCC) mice were intercrossed with F 1 non-A y (AaBBCC) mice to produce the F 2 generation. F 2 mice consisted of F 2 A y (A y ABBCC or A y aBBCC) and F 2 non-A y (AaBBCC or aaBBCC) mice. A y mice can be distinguished visually from non-A y mice by their yellow coat color. F 2 females were weaned at 4 weeks and housed in groups of 4-5 for 16 weeks.
All mice were maintained in a specific-pathogen-free facility with a regular light-dark cycle (12 hr light and 12 hr dark) and controlled temperature (23 ± 1°C) and humidity (50%). Food (CRF-1; Oriental Yeast Co., Ltd., Tokyo, Japan) and water were freely available throughout the experimental period. All animal experiments were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of NIAS.
Phenotyping: At the age of 16 weeks, mice were euthanized with an overdose of ether after 4 hr fasting. Whole blood was drawn from the heart into a plastic tube using heparin as an anticoagulant. Sample tubes were centrifuged at 7,000 rpm for 5 min at 4 °C to separate the plasma. The plasma samples were maintained at −70 °C until use.
Plasma glucose concentrations were determined by colorimetric detection using glucose C-II test Wako (Wako Pure Chemical Industries, Ltd., Osaka, Japan). Plasma insulin concentrations were determined using a mouse insulin ELISA kit (AKRIN-011T for the F 2 non-A y mice and AKRIN-011H for the F 2 A y mice, Shibayagi, Shibukawa, Japan). Plasma leptin concentrations were determined using a mouse leptin ELISA kit (AKRLP-011, Shibayagi).
The anal-nasal length of each mouse was measured using digital calipers to the nearest 0.01 mm just after blood collection. Body length was defined as the anal-nasal length in this study. Body mass index (BMI) was calculated as body weight (g)/[body length (mm)] 2 × 10 3 . BMI was used to estimate the degree of obesity.
Normality of distribution of the trait data for each F 2 strain was tested using the Shapiro-Wilk W test (JMP 8, SAS Institute Inc., Cary, NC, U.S.A.). If the trait values did not follow a normal distribution, they were appropriately normalized using the Box-Cox transformation or analyzed by a non-parametric method.
Genotyping and QTL analysis: Genomic DNA isolation and genotyping of microsatellite markers were performed as described in our previous study [21] . A list of the microsatellite markers used, with their map positions, is presented in Table 1 .
It should be noted that chromosome 7 is divided into 2 parts. As a consequence of the introgression of the Tyr locus from the B6 strain, the middle part of the DDD genome on chromosome 7 is replaced with the B6 genome in DDD-A y mice. In this study, a region proximal to the B6 region was defined as chromosome 7.1 (represented by D7Mit250), and a region distal to the B6 region was defined as chromosome 7.2 (represented by D7Mit362).
Of 298 F 2 female mice, 148 were F 2 non-A y , and 150 were F 2 A y . QTL analysis was performed using R/qtl [3, 4] . Threshold LOD scores for suggestive (P<0.63) and significant (P<0.05) linkages were determined by performing 1,000 permutations for each trait [11] . For significant QTLs, a 95% confidence interval (CI) was defined by a drop of 1.5 LOD. After these single QTL scans, pairwise tests for potential interactions between loci were conducted. At this stage, threshold LOD scores were based on those recommended by Broman and Sen [3] .
PC analysis: The comprehensive evaluation of metabolic traits was performed using principal component analysis by considering the three traits (glucose, insulin and leptin concentrations) as a single multivariate character.
Other statistics: Statistical analysis comparing two groups and more than 2 groups was performed using Student's or Welch's t-test and Tukey-Kramer HSD test, respectively. Strength of association among traits was evaluated using the Spearman rank correlation coefficient. P<0.05 was considered statistically significant.
RESULTS
Comparison of plasma glucose and leptin concentrations among DDD, DDD-A y , B6
, and B6-A y strain female mice: Table 2 shows mean ± SE plasma concentrations of glucose and leptin in parental strain females. DDD-A y mice had significantly higher plasma glucose concentration than DDD, B6-A y and B6 mice. There were no significant differences among the latter three strains. DDD-A y and B6-A y mice had significantly higher plasma leptin concentration than DDD and B6 mice, respectively. There were no significant differences between DDD-A y and B6-A y mice and between DDD and B6 mice.
Plasma glucose, insulin, and leptin concentrations in F 2 mice: Table 2 shows mean ± SE plasma concentrations of glucose, insulin and leptin in F 2 mice. F 2 A y mice had significantly higher glucose, insulin and leptin concentrations than F 2 non-A y mice.
Phenotypic correlations among traits are shown in Table  3 . In F 2 non-A y mice, BMI positively and significantly correlated with insulin and leptin concentrations, but not with glucose concentration. Glucose concentration positively and significantly correlated with insulin concentration, but not with leptin concentration. In F 2 A y mice, BMI positively and significantly correlated with insulin and leptin concentrations, but not with glucose concentration. Glucose concentration did not significantly correlate with any other traits.
PC analysis: Table 4 gives the eigenvalue and its contribution with respect to PC in F 2 non-A y and F 2 A y mice. Two PCs were successfully extracted for each F 2 type, although the second PC in F 2 non-A y mice was below 1.0. They accounted for approximately 73-80% of the variation in metabolic trait information in F 2 non-A y and F 2 A y mice. For the first PC (PC1), coefficients for all variables were positive in both F 2 types (Table 5) .
QTL mapping: The distributions of plasma glucose, insulin, and leptin concentrations in F 2 mice are shown in Supplementary Figs. 1, 2 and 3 (http://www.jstage.jst.go.jp/ browse/jvms), respectively. BMI was re-analyzed using R/ qtl. Because the merged BMI from F 2 non-A y and F 2 A y mice a), Apolipoprotein A-II (Apoa2) was genotyped by a PCR-RFLP method according to the Suto et al. [24] procedure. b), Map positions (cM) were based on a linkage map calculated using combined F 2 females (n=298). could not be normalized, BMI was standardized to mean 0 and variance 1 within each F 2 type before they were combined. In accordance with the results of our previous study [21] , four significant obesity QTLs were identified on chromosomes 1, 6, 9 and 17 (Table 6 and Fig. 1A) . Except for the QTL on chromosome 6, the DDD allele was associated with higher BMI. No significant pairwise interactions were identified. QTL scans were performed with the agouti locus genotype (A y or non-A y ) as a covariate. Because the difference between the LOD score with the agouti locus genotype as an interactive covariate and the LOD score with the agouti locus genotype as an additive covariate concerns the test of the QTL × agouti locus genotype interaction, this was performed. However, this test did not yield any significant QTL × covariate interactions. For the analysis of plasma glucose concentration, trait data for F 2 non-A y and F 2 A y mice were merged and normalized. Because F 2 A y mice had significantly higher glucose concentration than F 2 non-A y mice, the agouti locus genotype was included as an additive covariate. Single QTL scans identi-fied five suggestive QTLs on chromosomes 8, 10, 11, 13 and 18 in the combined F 2 mice (Table 7 and Fig. 1B ). There were no overlaps between QTLs for glucose concentration and BMI. No significant QTL × covariate interactions were identified.
The distribution of plasma insulin concentration was highly skewed and could not be normalized in F 2 non-A y and F 2 A y mice after Box-Cox transformation ( Fig. 2A, B) . Accordingly, plasma insulin concentration was analyzed by the non-parametric method. In F 2 non-A y mice, one significant QTL was identified on chromosome 12 (Table 8 and Fig.  1C ). Gene symbol Insdq1(insulin in DDD QTL no. 1) was assigned to this locus. At Insdq1, the DDD allele was associated with decreased insulin concentration ( Fig. 2A) . In F 2 A y mice, two significant QTLs were identified on chromosomes 6 and 12. The QTL on chromosome 12 overlapped with Insdq1, and the DDD allele at this QTL was associated with decreased insulin concentration ( Fig. 2A) . Accordingly, this QTL was considered allelic with Insdq1. The QTL on chromosome 6 was named Insdq2. The DDD allele was as- sociated with decreased insulin concentration at Insdq2 (Fig.  2B) . No significant pairwise interactions were identified in either F 2 types. Subsequently, we analyzed combined F 2 mice to assess the F 2 specificity with regard to the allele effect of QTLs identified above. To combine the data from F 2 A y and F 2 non-A y mice, insulin concentration was standardized within the two F 2 types. The standardized insulin concentration was still not normally distributed (Supplementary Fig. 4A ).
However, when the combined F 2 mice were analyzed by parametric and non-parametric methods, the results of single QTL scans by both methods were very similar (Fig. 3A) . The results from the non-parametric method are reported in Table  8 . Two significant QTLs were identified on chromosomes 6 and 12. QTL scans by the parametric method were also performed with the agouti locus genotype as a covariate, but no significant QTL × covariate interactions were identified.
Plasma leptin concentration followed a normal distribu- tion in F 2 A y mice, but not in F 2 non-A y mice. Accordingly, the trait in F 2 non-A y mice was analyzed by the non-parametric method. One significant QTL was identified on chromosome 17 (Table 9 and Fig. 1D ). Gene symbol Lepdq1(leptin in DDD QTL no. 1) was assigned to this locus. At Lepdq1, the DDD allele was associated with increased leptin concentration (Fig. 2C) . In F 2 A y mice, one significant QTL was identified on chromosome 1. Gene symbol Lepdq2 to this locus. At Insdq2, the DDD allele was associated with increased leptin concentration (Fig. 2D) . No significant pairwise interactions were identified in either F 2 types. Data regarding leptin concentrations in F 2 A y and F 2 non-A y mice were combined and analyzed in the same manner as those regarding insulin concentrations. The standardized leptin concentration was still not normally distributed (Supplementary Fig. 4B) . However, the results of single QTL scans by parametric and non-parametric methods were similar (Fig. 3B) . The results from the non-parametric method are reported in Table 9 . Three significant QTLs were identified on chromosomes 1, 6 and 17. The QTL on chromosome 6 was newly identified, and this QTL was named Lepdq3. The DDD allele at Lepdq3 was associated with decreased leptin concentration (Fig. 2E) . No significant QTL × covariate interactions were identified.
PC1 was analyzed as a non-parametric trait. Two significant QTLs were identified on chromosome 12 in F 2 non-A y mice (Table 10 and Fig. 1E ). Gene symbols Pc1dq1(PC1 in DDD QTL no. 1, proximal QTL) and Pc1dq2(distal QTL) were assigned to these QTLs. The DDD allele was associated with decreased PC1 values at both QTLs (Fig. 2F, 2G) . In F 2 A y mice, four significant QTLs were identified on chromosomes 1, 6, 12 and 17. The QTL on chromosome 12 overlapped with Pc1dq2, and the DDD allele was associated with decreased PC1 values (Fig. 2G) . Thus, this QTL was considered allelic with Pc1dq2. The QTLs on chromosome 1, 6 and 17 were named Pc1dq3, Pc1dq4 and Pc1dq5, respectively. The DDD allele was associated with increased PC1 values at Pc1dq3 (Fig. 2H) and decreased PC1 values at Pc1dq4 and Pc1dq5 (Fig. 2I, 2J) . No significant pairwise interactions were identified in either F 2 types.
PC1s from F 2 A y and F 2 non-A y mice were combined and analyzed in the same manner as data regarding insulin concentration. The standardized PC1 was still not normally distributed ( Supplementary Fig. 4C ). However, the results of single QTL scans by both methods were similar (Fig. 3C) .
The results from the non-parametric method are reported in Table 10 . Three significant QTLs were identified on chromosomes 1, 6, and 12. The QTL on chromosome 9 significantly interacted with the agouti locus genotype (Figs. 2K, 4) . Gene symbol Pc1dq6 was assigned to this QTL. The maximum LOD score for Pc1dq6 was 2.57, and the 95% CI extended from 0 to 44 cM; therefore, Pc1dq6 overlapped with Obdq2. Finally, QTLs on chromosome 6 (Obdq1, Insdq2, Lepdq3
and Pc1dq4) were further mapped with additional eight microsatellite markers to exclude the possibility that these QTLs were due to the so-called ghost QTLs (Table 11) . Consequently, presence of a single peak of QTL on mid-part of chromosome 6 was confirmed for all traits (Table 12 and Fig.  5 ). Although maximum LOD score was not substantially changed, 95% CI was slightly narrowed for each trait.
DISCUSSION
No significant QTLs were identified for glucose concentration. Moreover, no suggestive QTLs for glucose concentration overlapped any significant QTLs for other traits. In F 2 non-A y mice, the strength of phenotypic correlation between glucose concentration and other traits, except for that between glucose and insulin concentrations, was weak. Therefore, the genetic basis for glucose concentration was suggested to be different from that for the other traits.
Interestingly, the 95% CI for a locus on chromosome 8 overlapped with that for Giq1, a previously identified QTL for glucose tolerance in F 2 mice obtained by crossing B6 and KK-A y mice [22, 26] . In contrast to the locus on chromosome 
females (n=298). c) Reference map position (cM) was retrieved from Mouse
Genome informatics (http://www.informatics.jax.org/). Fig. 4 . Plots of interaction LOD score for PC1 in combined F 2 mice. A significant QTL × agouti locus genotype interaction was identified on chromosome 9. Threshold LOD scores for significant interaction were 2.56 for autosomes and 3.06 for the X chromosome.
8 in this study, the B6 allele at Giq1 was associated with decreased glucose concentration. Whether the 2 loci were allelic was unclear. The A y allele is known to induce hyperinsulinemia [17, 27] . Although we did not determine insulin concentration in parental strains, DDD-A y and B6-A y mice are expected to have higher insulin concentration than DDD and B6 mice, respectively. F 2 A y mice had significantly higher insulin concentration than F 2 non-A y mice. We identified two significant QTLs on chromosomes 12 (Insdq1) and 6 (Insdq2). The LOD score for Insdq1 increased in combined F 2 mice, whereas that for Insdq2 decreased in combined F 2 mice. Because we did not identify any QTL × agouti locus genotype interactions, the direction of the allele effect at Insdq1 and/or Insdq2 was suggested to be the same between F 2 non-A y and F 2 A y mice. Thus, Insdq1 should be regarded as a principal QTL for insulin concentration.
Among the QTLs identified for insulin concentration in mice, Kido et al. [9] mapped suggestive QTL for insulin on chromosome 12 with a peak LOD score 3.11 at D12Mit231. This QTL was located proximally to Insdq1, suggesting that Insdq1 is a novel QTL.
The A y allele significantly increased plasma leptin concentration. Increase in leptin concentration induced by the A y allele was more pronounced in the F 2 background.
It is reasonable that leptin QTLs co-localized with obesity QTLs because phenotypic correlations between the 2 traits were positive and significant and that leptin concentration is known to reflect the amount of fat. Indeed, the direction of the allele effect of leptin QTLs was the same as that of the obesity QTL; in other words, when the DDD allele was associated with enhanced obesity, it was associated with increased leptin concentration.
With respect to QTLs for leptin in obese mice, Kim et al. [10] reported a similar result. A congenic mouse strain B6.TH-tabw2/tabw2, which carries obesity QTL tabw2 from the obese TallyHo mouse strain, had increased plasma leptin concentrations compared with control B6.TH-+/+ mice. Interestingly, tabw2 co-localized with Obdq1 [21] and Bwq2 [23, 25] on chromosome 6.
Among leptin QTLs identified in this study, the peak LOD scores for Lepdq1 in F 2 non-A y mice and Lepdq2 in F 2 A y mice were not substantially changed in combined F 2 mice. Lepdq3 was identified as a significant QTL only in the combined F 2 mice. Given that we identified no QTL × agouti locus genotype interactions, there was no evidence that the direction of the allele effect at Lepdq1, Lepdq2 and/or Lepdq3 was opposite between F 2 non-A y and F 2 A y mice. Lepdq1 and Lepdq2 exhibited an apparent effect on leptin, but not on other traits. Thus, Lepdq1 and Lepdq2 were suggested to be involved primarily in obesity. Lepdq3 overlapped with Insdq2 and Obdq1 on chromosome 6, implying genetic relationships among leptin-insulin concentration, and obesity.
The genetic basis for leptin concentration has also been investigated in other mouse strains. Mlepq2, identified in an F 2 intercross between M16 and ICR strains [1] , coincided with Lepdq1 on distal chromosome 17. In accordance with the effect of Lepdq1 on obesity, Mlepq2 also colocalized with a QTL accounting for growth and the amount of body fat in that cross. Almind et al. [2] investigated the genetic bases for hyperleptinemia and hyperinsulinemia in mice. They identified significant QTLs for these two traits on separate chromosomes 7 and 14, respectively. Interestingly, the 2 loci interacted synergistically in the development of hyperinsulinemia, suggesting that a complex mechanism may underlie the metabolic control of leptin and insulin.
For PC1, coefficients for all variables were positive in both F 2 types, suggesting PC1 to be a factor responsible for the comprehensive evaluation of metabolic traits. Mice with larger PC1 are expected to have higher glucose, insulin, and leptin concentrations than mice with smaller PC1. In total, we identified six significant QTLs for PC1. Among the QTLs for PC1, we identified one significant QTL × agouti locus genotype interaction on chromosome 9 (Pc1dq6). The effect of Pc1dq6 was thus different in the two F 2 types (Fig.  2K) . Similarly, the allele effect of Pc1dq1 seemed to differ between the two F 2 types (Fig. 2F) ; however, the interaction was insignificant (Fig. 4) . Pc1dq1 was not identified when each trait was analyzed solely, but identified when PC1 was analyzed. As Pc1dq1 was significant only in F 2 non-A y mice, this was partly because LOD scores for insulin and leptin concentrations were higher in F 2 non-A y mice than in F 2 A y mice (Fig. 1C, D) , and because the B6 allele at D12Mit172(nearest marker to Pc1dq1) was associated with higher trait values for both traits (data not shown). There- fore, identification of Pc1dq1 is suggested to be a consequence of synergism of the effect for each trait. PC1 may be a well-extracted factor that represents combined pathologic condition of diabetes and obesity, because insulin and leptin concentrations are highly relevant to the diseases. Pc1dq4 overlapped with Obdq1 on chromosome 6, suggesting that the two QTLs have a metabolic effect associated with obesity. In contrast, Pc1dq2 did not overlap with any obesity QTLs. Indeed, the LOD score of a region of chromosome 12 for BMI was quite modest. Thus, Pc1dq2 exerts a strong metabolic effect without influencing obesity.
The results showed that all obesity QTLs had significant metabolic effects relevant to obesity and diabetes. In particular, Obdq1 on chromosome 6 seemed to exert the strongest metabolic effect among all obesity QTLs, because Obdq1 was the only obesity QTL that had overlapping QTLs for insulin and leptin concentrations. In addition to the obesity QTLs, QTL on chromosome 12 was revealed to have a strong metabolic effect. These findings will be helpful to identify genes that underline obesity QTLs.
